These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2244644)

  • 1. Dyskinetic movements, cognitive impairment, and negative symptoms in elderly neuropsychiatric patients.
    Karson CN; Bracha HS; Powell A; Adams L
    Am J Psychiatry; 1990 Dec; 147(12):1646-9. PubMed ID: 2244644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The profile of cognitive impairment in elderly dyskinetic subjects.
    Karson CN; Lyon N; Amick R; Bracha HS; Guggenheim FG
    J Neuropsychiatry Clin Neurosci; 1993; 5(1):61-5. PubMed ID: 8094020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of topography on the cognitive and psychopathological effects of tardive dyskinesia.
    Brown KW; White T
    Am J Psychiatry; 1992 Oct; 149(10):1385-9. PubMed ID: 1356314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive impairment in patients with tardive dyskinesia.
    Myslobodsky MS; Tomer R; Holden T; Kempler S; Sigal M
    J Nerv Ment Dis; 1985 Mar; 173(3):156-60. PubMed ID: 3973576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The psychological consequences of tardive dyskinesia. The effect of drug-induced parkinsonism and the topography of the dyskinetic movements.
    Brown KW; White T
    Br J Psychiatry; 1991 Sep; 159():399-403. PubMed ID: 1683594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of awareness of dyskinesia in schizophrenia to insight into mental illness.
    Arango C; Adami H; Sherr JD; Thaker GK; Carpenter WT
    Am J Psychiatry; 1999 Jul; 156(7):1097-9. PubMed ID: 10401460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive dysfunction in schizophrenia: organic vulnerability factor or state marker for tardive dyskinesia?
    Waddington JL; O'Callaghan E; Larkin C; Kinsella A
    Brain Cogn; 1993 Sep; 23(1):56-70. PubMed ID: 8105822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Negative symptoms, cognitive dysfunction, tardive akathisia and tardive dyskinesia.
    Sachdev P; Hume F; Toohey P; Doutney C
    Acta Psychiatr Scand; 1996 Jun; 93(6):451-9. PubMed ID: 8831862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sub-syndromes of tardive dyskinesia and some clinical correlates.
    Brown KW; White T
    Psychol Med; 1992 Nov; 22(4):923-7. PubMed ID: 1488488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Schizophrenic deficit syndrome and neurologic tolerance].
    Verdoux H; Bourgeois M
    Encephale; 1996 Jun; 22 Spec No 2():45-7. PubMed ID: 8767042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Psychopathology and cognitive disorders in chronic schizophrenic patients with tardive dyskinesia].
    Kaiser W
    Nervenarzt; 1989 Apr; 60(4):206-12. PubMed ID: 2566936
    [No Abstract]   [Full Text] [Related]  

  • 12. Cognitive dysfunction in schizophrenia followed up over 5 years, and its longitudinal relationship to the emergence of tardive dyskinesia.
    Waddington JL; Youssef HA; Kinsella A
    Psychol Med; 1990 Nov; 20(4):835-42. PubMed ID: 1980953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of the selective serotonin 3 receptor antagonist ondansetron in the treatment of neuroleptic-induced tardive dyskinesia.
    Sirota P; Mosheva T; Shabtay H; Giladi N; Korczyn AD
    Am J Psychiatry; 2000 Feb; 157(2):287-9. PubMed ID: 10671405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tardive dyskinesia and type II schizophrenia.
    Davis EJ; Borde M; Sharma LN
    Br J Psychiatry; 1992 Feb; 160():253-6. PubMed ID: 1347240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of subjective and objective quality of life in outpatients with schizophrenia.
    Yamauchi K; Aki H; Tomotake M; Iga J; Numata S; Motoki I; Izaki Y; Tayoshi S; Kinouchi S; Sumitani S; Tayoshi S; Takikawa Y; Kaneda Y; Taniguchi T; Ishimoto Y; Ueno S; Ohmori T
    Psychiatry Clin Neurosci; 2008 Aug; 62(4):404-11. PubMed ID: 18778437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive sequelae of tardive dyskinesia.
    DeWolfe AS; Ryan JJ; Wolf ME
    J Nerv Ment Dis; 1988 May; 176(5):270-4. PubMed ID: 2896762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Negative symptoms, tardive dyskinesia and depression in chronic schizophrenia.
    Barnes TR; Liddle PF; Curson DA; Patel M
    Br J Psychiatry Suppl; 1989 Nov; (7):99-103. PubMed ID: 2575915
    [No Abstract]   [Full Text] [Related]  

  • 18. Cognitive functions in tardive dyskinesia.
    Wolf ME; Ryan JJ; Mosnaim AD
    Psychol Med; 1983 Aug; 13(3):671-4. PubMed ID: 6137851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Negative symptoms: relationship to other schizophrenic symptom classes.
    McKenna PJ; Lund CE; Mortimer AM
    Br J Psychiatry Suppl; 1989 Nov; (7):104-7. PubMed ID: 2619978
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of verapamil on tardive dyskinesia and psychosis in schizophrenic patients.
    Reiter S; Adler L; Angrist B; Peselow E; Rotrosen J
    J Clin Psychiatry; 1989 Jan; 50(1):26-7. PubMed ID: 2562952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.